Stock Comparison
HLN vs TEVA
Haleon plc and Teva Pharma Industries Ltd ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$40.72B
$38.67B
P/E (TTM)
18.9
24.8
Forward P/E
17.5
16.0
Price/Sales
3.7
2.2
Price/Book
1.9
4.7
EV/EBITDA
13.3
16.3
Dividend Yield
2.09%
—
Profitability
Net Margin
15.10%
9.02%
Operating Margin
23.20%
19.20%
Return on Equity
10.30%
21.60%
Return on Assets
4.67%
6.38%
Growth (YoY)
Revenue Growth
0.60%
2.30%
Earnings Growth
92.00%
72.20%
Price & Risk
Beta
0.2
0.9
52-Week High
$11.13
$37.35
52-Week Low
$8.60
$14.99
Analyst Target
$11.69
$40.90
Compare HLN and TEVA your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.